Mai-Britt Zocca

Insider Reports History

Identity Names, identifiers, and filing context for this profile. 1 identity field
Reporting-owner location
Wilmington, DE
SEC source record Original filing metadata and source links for verification. 1 source field
Latest reporting-owner signature
/s/ Brian Burkavage, Attorney-in-Fact for Mai-Britt Zocca
Source: Latest parsed Forms 3/4/5 signature
Source evidence Original filing metadata and source links for verification. 1 source field
Transaction source note
Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for Mai-Britt Zocca

Form 4 holding Chief Executive Officer, Director

IO Biotech, Inc.

Security class
Common Stock
Shares / value
49,891
Estimated value
$40,392
Report date
23 Dec 2024
Price
$0.8096
Ownership
Direct
Form 4 holding Chief Executive Officer, Director

IO Biotech, Inc.

Security class
Common Stock
Shares / value
26,580
Estimated value
$21,519
Report date
23 Dec 2024
Price
$0.8096
Ownership
Zocca Consulting ApS
Form 4 holding Chief Executive Officer, Director

IO Biotech, Inc.

Security class
Stock Option (Right to Buy)
Shares / value
580,000
Estimated value
Report date
02 Apr 2025
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Insider Reports Filed by Mai-Britt Zocca

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .